930
Participants
Start Date
March 7, 2017
Primary Completion Date
August 29, 2017
Study Completion Date
August 30, 2017
IVACFLU-A/H5N1 vaccine
Monovalent A/H5N1 influenza vaccine (MIV), whole virion inactivated, purified by sucrose gradient on ultracentrifuge. The vaccine was produced in eggs, inactivated with formaldehyde, and formulated with aluminum hydroxide 0.6 mg/0.5 mL with no preservative.
Placebo
Includes 4.500mg sodium chloride, 0.685 mg sodium phosphate dibasic dihydrate, and 0.186 mg sodium phosphate monobasic dihydrate.
Phase 3: Hai Phong Provincial Preventive Medicine Center, Haiphong
Phase 2 & 3: Khanh Hoa Provincial Health Department, Nha Trang
National Institute of Hygiene and Epidemiology, Vietnam
OTHER
World Health Organization
OTHER
Department of Health and Human Services
FED
PATH
OTHER
FHI 360
OTHER
Institute of Vaccines and Medical Biologicals, Vietnam
INDUSTRY